FdaApplication
NDA 217564
Identifiers
- fda_app_no: NDA217564
Properties
| Property | Value |
|---|---|
| applicant_name | TAKEDA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2023-11-08 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FRUZAQLA | FRUQUINTINIB | 1MG | CAPSULE;ORAL |
| FRUZAQLA | FRUQUINTINIB | 5MG | CAPSULE;ORAL |
2 products